Lipella Pharmaceuticals I... (LIPO)
NASDAQ: LIPO
· Real-Time Price · USD
0.56
-0.00 (-0.25%)
At close: Oct 03, 2025, 11:22 AM
0.56
0.00%
Pre-market: Oct 03, 2025, 11:22 AM EDT
-0.25% (1D)
| Bid | 0.56 |
| Market Cap | 2.59M |
| Revenue (ttm) | 216.37M |
| Net Income (ttm) | -1.31B |
| EPS (ttm) | -3.33 |
| PE Ratio (ttm) | -0.17 |
| Forward PE | -0.03 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 0.6 |
| Volume | 37 |
| Avg. Volume (20D) | 5,673 |
| Open | 0.56 |
| Previous Close | 0.56 |
| Day's Range | 0.56 - 0.56 |
| 52-Week Range | 0.53 - 7.31 |
| Beta | -0.05 |
| Ex-Dividend Date | n/a |
About LIPO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LIPO
Website n/a
7 months ago
+41.64%
Lipella Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
8 months ago
+80.23%
Lipella Pharmaceuticals shares are trading higher after the company received FDA approval for an expanded access program for LP-310 in oral lichen planus.
